|
Basic Characteristics of Mutations
|
|
Mutation Site
|
V170I |
|
Mutation Site Sentence
|
We detected NS3/4A protease major and minor variants associated with resistance to boceprevir (V36L), telaprevir (V36L, I132V), simeprevir (V36L), and grazoprevir (V36L, V170I). |
|
Mutation Level
|
Amino acid level |
|
Mutation Type
|
Nonsynonymous substitution |
|
Gene/Protein/Region
|
NS3-4A |
|
Standardized Encoding Gene
|
NS3-4A
|
|
Genotype/Subtype
|
1b |
|
Viral Reference
|
AJ238799
|
|
Functional Impact and Mechanisms
|
|
Disease
|
HCV Infection
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
grazoprevir |
|
Location
|
Italy |
|
Literature Information
|
|
PMID
|
27618896
|
|
Title
|
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naive Patients
|
|
Author
|
Marascio N,Pavia G,Strazzulla A,Dierckx T,Cuypers L,Vrancken B,Barreca GS,Mirante T,Malanga D,Oliveira DM,Vandamme AM,Torti C,Liberto MC,Foca A
|
|
Journal
|
International journal of molecular sciences
|
|
Journal Info
|
2016 Aug 27;17(9):1416
|
|
Abstract
|
Naturally occurring resistance-associated substitutions (RASs) can negatively impact the response to direct-acting antivirals (DAAs) agents-based therapies for hepatitis C virus (HCV) infection. Herein, we set out to characterize the RASs in the HCV1b genome from serum samples of DAA-naive patients in the context of the SINERGIE (South Italian Network for Rational Guidelines and International Epidemiology, 2014) project. We deep-sequenced the NS3/4A protease region of the viral population using the Ion Torrent Personal Genome Machine, and patient-specific majority rule consensus sequence summaries were constructed with a combination of freely available next generation sequencing data analysis software. We detected NS3/4A protease major and minor variants associated with resistance to boceprevir (V36L), telaprevir (V36L, I132V), simeprevir (V36L), and grazoprevir (V36L, V170I). Furthermore, we sequenced part of HCV NS5B polymerase using Sanger-sequencing and detected a natural RAS for dasabuvir (C316N). This mutation could be important for treatment strategies in cases of previous therapy failure.
|
|
Sequence Data
|
KX373275-KX373290
|
|
|